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This is an open access artiIntroductionEnterococci are important opportunistic pathogens and have
become increasingly known as a signiﬁcant cause of nosocomial
and community-acquired infections; Enterococcus faecalis and
E. faecium are the most common species implicated [1]. E. hirae
is known to cause infections in animals but is rarely isolated
from human clinical samples [2]. In the present report, we
describe a case of E. hirae causing urinary tract infection in a
diabetic man with benign prostatic hyperplasia. This case rep-
resents the ﬁrst report of infection by this organism in Algeria.Case reportA 50-year-old man presented with a medical history of diabetes
mellitus type 2 and had prostate enlargement for approximately
1 year. He was previously hospitalized twice as a result of an
inability to fully empty his bladder. He underwent urinary
catheterization; however, no antibacterial therapy was admin-
istered. The last hospitalization was 2 months before this pre-
sent admission.
Clinically, the patient presented with symptoms shared be-
tween benign prostatic hyperplasia, including straining to uri-
nate, weak urine stream and inability to fully empty the bladder,
and symptomatic lower urinary tract infection, including dysuria
with cloudy urine, suprapubic pain, urinary frequency and ur-
gency. The patient had a negative blood culture; however, the
microscopic analysis of urine indicated the presence of white
blood cells (>10 leukocytes per high-power ﬁeld). The urine
culture was positive, and the isolate was identiﬁed at the genus
level using phenotypic methods including Gram staining, cata-
lase test and growth on bile esculin azide agar and 6.5% NaCl
media. The primary bacteriologic diagnosis indicated that the
isolated strain belonged to the genus Enterococcus. The
biochemical identiﬁcation using an API 20 Strep system (bio-
Mérieux, Marcy l’Etoile, France) could not identify the species
involved. Characterization of the clinical isolate to the species
level was achieved by MALDI-TOF MS (matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry)
(Microﬂex; Bruker Daltonics, Bremen, Germany) using Flex
Control and Biotyper 3.0 software (Bruker Daltonics) as pre-
viously described [3]. The identiﬁcation of the strain by MALDI-
TOF MS revealed the E. hirae species, with a correct identiﬁ-
cation score of 2.263. The isolate was multisensitive against
nearly all antibiotics tested, including high-level (HL) amino-
glycosides (HL gentamicin and HL kanamycin), ampicillin, line-
zolid, ciproﬂoxacin, nitrofuran and vancomycin. However, theNew Microbe and New Infect 2015; 8: 7–9
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azole. The patient received oral treatment with antimicrobial
combinations of ampicillin and gentamicin for 10 days. A ure-
thral catheter was inserted for 5 days to empty the bladder.
Urine samples were analyzed during treatment until the culture
result was negative. The clinical status of the patient improved
after 5 days of hospitalization, and the patient was discharged
and continued antibiotic therapy at home.DiscussionUrinary tract infection (UTI) caused by enterococci is very
common and is primarily due to E. faecalis and E. faecium spe-
cies [4]. Most cases of urinary tract infections occur in women
and are uncommon in men [5]. Prostate enlargement, also
called benign prostatic hyperplasia, represents an important risk
factor for UTI and bacterial prostatitis in men [5,6]. This
structural abnormality is mainly associated with aging and most
often affects men who are 60 years of age and older [7]. This
chronic condition can prevent the bladder from emptying
completely, which increases the likelihood that bacteria will
grow and trigger an infection [6].
In our case, we report the occurrence of symptomatic lower
UTI in a diabetic man with an enlarged prostate caused by an
unusual pathogen in humans, E. hirae. Clinical diagnosis of ourTABLE 1. Case reports of Enterococcus hirae in human infections
Patient
no.
Age (years)/sex,
country
Diagnosis Predisposing factors Meth
ide
1 49/M, Israel Septicemia Hemodialysis catheter Rapid
(bi
Fra
2 72/M, France Native valve
Endocarditis
Coronary artery disease (sodA
3 55/M, Spain Spondylodiscitis Diabetes mellitus VITE
(bi
ge
4 78/F, France Infective endocarditis Diabetes mellitus,
bioprosthetic valve
16S r
sod
5 62/F, Taiwan Acute pyelonephritis Unidentiﬁed BD P
Ino
(B
Fra
mu
6 86/F, Taiwan Acute cholangitis Unidentiﬁed BD P
Ino
(B
mu
7 61/M, Korea Bacterial peritonitis Liver cirrhosis Auto
W
sug
8 44/M, France Bacteremia
Pyonephrosis
Alcoholic liver disease Unde
9 56/M, Brazil Native Valve
Endocarditis
Diabetes, cardiac arrhythmia
with surgical ablation
Unde
10 50/M, Algeria Symptomatic
lower UTI
BPH, diabetes mellitus,
urinary catheterization
MAL
AMK, amikacin; AMP, ampicillin; AMX, amoxicillin; BPH, benign prostatic hyperplasia; CFM, c
MALDI-TOF MS, matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometr
aMuramidase gene (mur-2) of E. hirae.
bGene encoding manganese-dependent superoxide dismutase.
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urinary tract based on the absence of clinical signs related to
upper UTI, such as ﬂank pain, vomiting and nausea [4], and to
prostatitis, such as prostate pain, fever, chills, body aches and
perineal pain [5,8]. Notably, in addition to prostate enlarge-
ment, urinary tract instrumentation, infection with HIV, in-
terventions of the male urogenital tract and underlying illnesses,
such as diabetes, are the main predisposing risk factors for UTI
in men [8,9]. In the current case, benign prostatic hyperplasia
was the main factor for the occurrence of UTI. Nonetheless,
diabetes and urinary catheter indwelling performed for this
patient during the previous hospitalizations represent also two
other factors that may increase the risk of UTI.
The causative agent isolated in this case was identiﬁed as
E. hirae. This species causes infections in animals, but reported
cases in humans are rare [2]. This species was identiﬁed for the
ﬁrst time in young chickens [4]. The ﬁrst report of a human
infection caused by E. hirae was described in 1998 by Gilad et al.
[10] in a case of septicemia in a 49-year-old man with renal
insufﬁciency treated with hemodialysis. Since then, few cases
have been described in humans [2,4] (Table 1). Notably, among
all enterococcal infections in humans, the low incidence of
E. hirae species has previously been described [1,4]. The bac-
terium may be underdiagnosed or misdiagnosed by standard
identiﬁcation approaches [4]. Our case demonstrates that
MALDI-TOF MS is an important tool useful for rapidly andod of E. hirae
ntiﬁcation
Source of
sample
Antibiotic treatment Reference
ID 32 Strep system
oMérieux, Marcy l’Etoile,
nce)
Blood VAN [10]
int gene)
b sequencing Blood AMP, GEN, RIF, VAN [15]
K 2 automated system
oMérieux); 16S rRNA
ne sequencing
Blood AMP, GEN, LEV, SXT [13]
RNA sequencing;
Aint gene sequencing
Blood AMP, GEN, RIF [16]
hoenix ID/AST Panel
culation System
ecton Dickinson,
nklin Lakes, NJ, USA);
r-2 genea sequencing
Blood
Urine
AMX [4]
hoenix ID/AST Panel
culation System
ecton Dickinson);
r-2 genea sequencing
Blood CFM [4]
mated MicroScan
alkAway system;
ar fermentation tests
Blood
Ascetic ﬂuid
AMP [17]
termined Blood
Urine
Kidney biopsy
AMX, CFT, AMK [14]
termined Blood AMP, RIF, AMX [2]
DI-TOF MS Urine AMP, GEN This study
efmetazole; CFT, ceftriaxone; CIP, ciproﬂoxacin; GEN, gentamicin; LEV, levoﬂoxacin;
y; RIF, rifampin; SXT, trimethoprim/sulfamethoxazole; VAN, vancomycin.
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any complementary tests. The ability of MALDI-TOF MS to
identify bacterial colonies from agar was evaluated for a broad
range of clinically relevant bacterial strains. The proper identi-
ﬁcation to the species level is achieved in 80–95% of bacterial
isolates [11]. Although the strain isolated in our patient showed
a sensitive proﬁle against the majority of antibiotics tested, the
study of Robredo et al. [12] showed that this species may
harbour vancomycin resistance genes and may participate in
their transmission to other species of enterococci. The resis-
tance of E. hirae to ampicillin and high-level gentamicin has also
been reported [13]. More importantly, enterococci long-term
urinary tract colonization can worsen and can lead to subse-
quent invasive infections, such as bacteraemia [4,14].
In conclusion, we report the ﬁrst case of symptomatic UTI
involving E. hirae in a patient with benign prostatic hyperplasia
from Algeria; this is the ﬁrst report describing E. hirae in this
country. This case emphasizes that MALDI-TOF MS is a
powerful diagnostic tool for fast and accurate identiﬁcation of
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